Neuroimaging and Neuromonitoring in Critically Ill Children With Sepsis
NCT ID: NCT03055455
Last Updated: 2021-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8 participants
OBSERVATIONAL
2017-02-01
2019-09-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pediatric Blunt Abdominal Trauma Clinical Prediction Model
NCT02206698
Descriptive Analysis of Near Infrared Spectroscopy in Critically Ill and Injured Pediatric and Neonatal Patients
NCT02950181
CEUS Evaluation of Hypoxic Ischemic Injury
NCT03549520
Pediatric Guideline Adherence and Outcomes- Argentina
NCT03896789
Severe Sepsis in Children - IMPRESS-C
NCT02598674
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sepsis
Children with severe sepsis or septic shock
MR imaging
Conventional structural imaging will be combined with advanced neuroimaging modalities to evaluate integrity of white matter tracts, regional brain perfusion, and the 3-dimensional volume of specific brain structures.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MR imaging
Conventional structural imaging will be combined with advanced neuroimaging modalities to evaluate integrity of white matter tracts, regional brain perfusion, and the 3-dimensional volume of specific brain structures.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males or females ages ≥ 3.5 years and ≤ 18 years on day of sepsis recognition
* Meet published consensus criteria for severe sepsis or septic shock: a) ≥ 2 systemic inflammatory response syndrome criteria, b) suspected (based on attending physician) or confirmed systemic infection, and c) ≥ 2 or more organ system dysfunctions (severe sepsis) or cardiovascular dysfunction (septic shock).
* An indwelling arterial catheter.
* Parental/guardian permission (informed consent).
* The patient and parent/guardian are fluent in English.
Exclusion Criteria
* History of cancer or undergoing treatment for cancer.
* Meningitis or encephalitis as source of sepsis.
* Congenital heart disease.
* History of cardiac arrest.
* History of extracorporeal membrane oxygenation (ECMO) cannulation.
* Patients with contraindications to MR scanning.
* Pregnant or lactating females.
* Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
* Previous enrollment in this study.
3 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Philadelphia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew Kirschen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHOP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-012645
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.